These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 37561229)

  • 1. Data mining and molecular dynamics analysis to detect HIV-1 reverse transcriptase RNase H activity inhibitor.
    Ghafoor NA; Kırboğa KK; Baysal Ö; Süzek BE; Silme RS
    Mol Divers; 2024 Aug; 28(4):1869-1888. PubMed ID: 37561229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, biological evaluation and molecular modeling of 2-Hydroxyisoquinoline-1,3-dione analogues as inhibitors of HIV reverse transcriptase associated ribonuclease H and polymerase.
    Tang J; Vernekar SKV; Chen YL; Miller L; Huber AD; Myshakina N; Sarafianos SG; Parniak MA; Wang Z
    Eur J Med Chem; 2017 Jun; 133():85-96. PubMed ID: 28384548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and antiviral evaluation of novel heteroarylcarbothioamide derivatives as dual inhibitors of HIV-1 reverse transcriptase-associated RNase H and RDDP functions.
    Corona A; Onnis V; Deplano A; Bianco G; Demurtas M; Distinto S; Cheng YC; Alcaro S; Esposito F; Tramontano E
    Pathog Dis; 2017 Aug; 75(6):. PubMed ID: 28859311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Docking and Molecular Dynamics Simulation Based Approach to Explore the Dual Inhibitor Against HIV-1 Reverse Transcriptase and Integrase.
    Chander S; Pandey RK; Penta A; Choudhary BS; Sharma M; Malik R; Prajapati VK; Murugesan S
    Comb Chem High Throughput Screen; 2017; 20(8):734-746. PubMed ID: 28641512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of Benzisothiazolone Derivatives as Bifunctional Inhibitors of HIV-1 Reverse Transcriptase DNA Polymerase and Ribonuclease H Activities.
    Vázquez Rivera A; Donald H; Alaoui-El-Azher M; Skoko JJ; Lazo JS; Parniak MA; Johnston PA; Sluis-Cremer N
    Biomolecules; 2024 Jul; 14(7):. PubMed ID: 39062532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 2-Hydroxyisoquinoline-1,3-Dione Active-Site RNase H Inhibitor Binds in Multiple Modes to HIV-1 Reverse Transcriptase.
    Kirby KA; Myshakina NA; Christen MT; Chen YL; Schmidt HA; Huber AD; Xi Z; Kim S; Rao RK; Kramer ST; Yang Q; Singh K; Parniak MA; Wang Z; Ishima R; Sarafianos SG
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28760905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combinatorial selection, inhibition, and antiviral activity of DNA thioaptamers targeting the RNase H domain of HIV-1 reverse transcriptase.
    Somasunderam A; Ferguson MR; Rojo DR; Thiviyanathan V; Li X; O'Brien WA; Gorenstein DG
    Biochemistry; 2005 Aug; 44(30):10388-95. PubMed ID: 16042416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of foamy virus reverse transcriptase by human immunodeficiency virus type 1 RNase H inhibitors.
    Corona A; Schneider A; Schweimer K; Rösch P; Wöhrl BM; Tramontano E
    Antimicrob Agents Chemother; 2014 Jul; 58(7):4086-93. PubMed ID: 24798282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissecting the effects of DNA polymerase and ribonuclease H inhibitor combinations on HIV-1 reverse-transcriptase activities.
    Shaw-Reid CA; Feuston B; Munshi V; Getty K; Krueger J; Hazuda DJ; Parniak MA; Miller MD; Lewis D
    Biochemistry; 2005 Feb; 44(5):1595-606. PubMed ID: 15683243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the DNA polymerase and RNase H activities of HIV-1 reverse transcriptase and HIV-1 replication by Brasenia schreberi (Junsai) and Petasites japonicus (Fuki) components.
    Hisayoshi T; Shinomura M; Yokokawa K; Kuze I; Konishi A; Kawaji K; Kodama EN; Hata K; Takahashi S; Nirasawa S; Sakuda S; Yasukawa K
    J Nat Med; 2015 Jul; 69(3):432-40. PubMed ID: 25663480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery, optimization, and target identification of novel coumarin derivatives as HIV-1 reverse transcriptase-associated ribonuclease H inhibitors.
    Kang D; Urhan Ç; Wei F; Frutos-Beltrán E; Sun L; Álvarez M; Feng D; Tao Y; Pannecouque C; De Clercq E; Menéndez-Arias L; Liu X; Zhan P
    Eur J Med Chem; 2021 Dec; 225():113769. PubMed ID: 34403976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis of the allosteric inhibitor interaction on the HIV-1 reverse transcriptase RNase H domain.
    Christen MT; Menon L; Myshakina NS; Ahn J; Parniak MA; Ishima R
    Chem Biol Drug Des; 2012 Nov; 80(5):706-16. PubMed ID: 22846652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutting into the Substrate Dominance: Pharmacophore and Structure-Based Approaches toward Inhibiting Human Immunodeficiency Virus Reverse Transcriptase-Associated Ribonuclease H.
    Wang L; Sarafianos SG; Wang Z
    Acc Chem Res; 2020 Jan; 53(1):218-230. PubMed ID: 31880912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of a dihydroxycoumarin active-site inhibitor in complex with the RNase H domain of HIV-1 reverse transcriptase and structure-activity analysis of inhibitor analogs.
    Himmel DM; Myshakina NS; Ilina T; Van Ry A; Ho WC; Parniak MA; Arnold E
    J Mol Biol; 2014 Jul; 426(14):2617-31. PubMed ID: 24840303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of Structure-based Methods to Analyze Resistance Mutations for Chemically Diverse Non-Nucleoside Reverse Transcriptase Inhibitors.
    Tabassum T; Azeem SM; Muwonge AN; Frey KM
    Curr HIV Res; 2020; 18(4):283-291. PubMed ID: 32493197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-target activity of Hemidesmus indicus decoction against innovative HIV-1 drug targets and characterization of Lupeol mode of action.
    Esposito F; Mandrone M; Del Vecchio C; Carli I; Distinto S; Corona A; Lianza M; Piano D; Tacchini M; Maccioni E; Cottiglia F; Saccon E; Poli F; Parolin C; Tramontano E
    Pathog Dis; 2017 Aug; 75(6):. PubMed ID: 28637198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Per-residue energy decomposition pharmacophore model to enhance virtual screening in drug discovery: a study for identification of reverse transcriptase inhibitors as potential anti-HIV agents.
    Cele FN; Ramesh M; Soliman ME
    Drug Des Devel Ther; 2016; 10():1365-77. PubMed ID: 27114700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developing and Evaluating Inhibitors against the RNase H Active Site of HIV-1 Reverse Transcriptase.
    Boyer PL; Smith SJ; Zhao XZ; Das K; Gruber K; Arnold E; Burke TR; Hughes SH
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29643235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug targeting of HIV-1 RNA.DNA hybrid structures: thermodynamics of recognition and impact on reverse transcriptase-mediated ribonuclease H activity and viral replication.
    Li TK; Barbieri CM; Lin HC; Rabson AB; Yang G; Fan Y; Gaffney BL; Jones RA; Pilch DS
    Biochemistry; 2004 Aug; 43(30):9732-42. PubMed ID: 15274628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational analysis of Tyr-501 of HIV-1 reverse transcriptase. Effects on ribonuclease H activity and inhibition of this activity by N-acylhydrazones.
    Arion D; Sluis-Cremer N; Min KL; Abram ME; Fletcher RS; Parniak MA
    J Biol Chem; 2002 Jan; 277(2):1370-4. PubMed ID: 11684697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.